For the year ending 2025-12-31, NBIX has $4,631,500K in assets. $1,378,400K in debts. $713,000K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 713,000 | |||
| Available-for-sale debt securities | 767,400 | |||
| Accounts receivable | 686,800 | |||
| Inventory | 69,000 | |||
| Prepaid expenses | 170,700 | |||
| Other current assets | 115,800 | |||
| Total current assets | 2,522,700 | |||
| Deferred tax assets | 320,300 | |||
| Available-for-sale debt securities | 1,063,000 | |||
| Right-of-use assets | 455,400 | |||
| Equity investments | 120,800 | |||
| Property and equipment, net | 89,800 | |||
| Other noncurrent assets | 59,500 | |||
| Total assets | 4,631,500 | |||
| Accounts payable and accrued liabilities | 674,300 | |||
| Other current liabilities | 69,100 | |||
| Total current liabilities | 743,400 | |||
| Noncurrent operating lease liabilities | 415,300 | |||
| Other noncurrent liabilities | 219,700 | |||
| Total liabilities | 1,378,400 | |||
| Additional paid-in capital | 2,792,200 | |||
| Accumulated other comprehensive income | 13,100 | |||
| Retained earnings | 447,700 | |||
| Total stockholders equity | 3,253,100 | |||
| Total liabilities and stockholders equity | 4,631,500 | |||
NEUROCRINE BIOSCIENCES INC (NBIX)
NEUROCRINE BIOSCIENCES INC (NBIX)